Vibe Bio is a Cambridge-based venture capital and strategic biotech investor backing early-stage companies developing cures for rare and overlooked diseases. It focuses on U.S. biotechnology, pharmaceuticals and life sciences opportunities, combining capital with AI-driven biopharma diligence and business-development infrastructure to help advance overlooked drug programs toward patients.